Sign in: Staff/Students
Life-saving research from the University of Liverpool into rotavirus, the leading cause of severe childhood diarrhoea, is today being celebrated as one of the UK’s 100 best breakthroughs for its transformational impact on child health across the world.
Work led by Professor Nigel Cunliffe at the Institute of Infection and Global Health has played a key role in the introduction and evaluation of a vaccine for the highly infectious stomach bug, which kills around 200,000 infants and children each year and hospitalises many more.
The UK’s Best Breakthroughs list demonstrates how UK universities are at the forefront of some of the world’s most important discoveries, innovations and social initiatives. It was compiled by Universities UK as part of the MadeAtUni campaign to change public perceptions of universities and bring to life the difference they make to people, lives and communities across the UK.
For the past 20 years, Professor Cunliffe has directed a long-term programme of rotavirus research in children in Malawi. This included a pivotal first clinical trial of a human rotavirus vaccine in Africa, which informed a global vaccine recommendation by the World Health Organisation in 2009 and the subsequent introduction of rotavirus vaccine into Malawi’s childhood immunisation schedule in 2012. The UK followed in 2013, and rotavirus vaccine is now part of the vaccination schedule in 96 countries around the world. A recent evaluation of the impact of rotavirus vaccine in Malawi showed that it has reduced infant diarrhoea deaths by nearly one-third. In Merseyside, gastrointestinal illness has fallen markedly since rotavirus vaccine introduction, with the greatest impact seen in the most deprived communities.
Professor Cunliffe said: “I’m absolutely delighted that our rotavirus work has been chosen as one of the UK’s top research breakthroughs. It’s all down to the incredible team effort of colleagues here in Liverpool with our collaborators and partners from Malawi and across the globe.
“We have already seen a major decrease in illnesses, hospitalisations and deaths from rotavirus diarrhoea around the world, but there is still work to be done. This includes helping every child receive the best protection against rotavirus regardless of where they are born.”
Professor Dame Janet Beer, vice-chancellor of the University and president of Universities UK said: “Universities really do transform lives. The technology we use every day, the medicines that save lives, the teachers who inspire – all come from UK universities and the important work being done by academics.
“The UK’s Best Breakthroughs list is a testament to the difference that universities make to people’s lives and we want everyone to join us in celebrating the work they do.”
As part of the MadeAtUni campaign, every university in the country was invited to nominate the one thing from their institution which they believe has had the biggest impact on people, lives or communities. Over 100 universities submitted a nomination. The entries cover health, technology, environment, family, community, and culture and sport.
You can find out more about the UK’s Best Breakthroughs and the MadeAtUni campaign here MadeAtUni.org.uk
You must be logged in to post a comment.
All recent news
Large Hadron Collider takes first data in record-breaking run
Meet 10 Amazing #LivUniGrads
Liverpool physicists reflect on ten years since the Higgs boson discovery
New landmark £2.3m Liverpool-led clinical trial launched
Shortlist for third John McGahern Annual Book Prize announced
New £2.3m trial aims to find out whether long-term #antibiotic treatment can reduce the impact that chest infections have on children with neurological impairment: https://news.liverpool.ac.uk/2022/07/04/new-landmark-2-3m-liverpool-led-clinical-trial-launched/
Postcard: @LivuniIPH urban food research draws the crowds at #Glastonbury➡️https://bit.ly/3ug65NS
Stalling improvements in #cardiovascular disease rates could cost UK £54bn, new @PLOSONE research suggests: https://news.liverpool.ac.uk/2022/06/29/stalling-improvements-in-cardiovascular-disease-rates-since-2010-could-cost-54bn-between-2020-and-2029/